{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:39:27Z","timestamp":1776695967273,"version":"3.51.2"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ferring B.V., the Netherlands."},{"DOI":"10.13039\/501100004914","name":"Ferring B.V., the Netherlands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gender-affirming hormone treatment is known to affect adrenal androgen levels in adult individuals with gender dysphoria (GD). This may be clinically relevant because the adrenal gland plays a critical role in many different metabolic processes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>This study aims to assess the effects of gonadotropin-releasing hormone analogs (GnRHa) treatment and gender-affirming hormone treatment on adrenal androgen levels in adolescents with GD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this prospective study, dehydroepiandrosterone-sulfate (DHEAS) and androstenedione values were measured every 6 months during 2 years of GnRHa treatment only, and 2 years of GnRHa combined with gender-affirming hormone treatment (estradiol or testosterone) in 73 transgirls and 54 transboys. To determine trends in adrenal androgen levels a linear mixed model was used to approximate androgen levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>DHEAS and androstenedione levels were the main outcome measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>DHEAS levels rose in transboys during GnRHa treatment, which may represent the normal increase during adolescence. In transgirls no change in DHEAS levels during GnRHa treatment was found. Gender-affirming hormone treatment did not affect DHEAS levels in either sex. In transboys androstenedione levels decreased during the first year of GnRHa treatment, which may reflect reduced ovarian androstenedione synthesis, and rose during the first year of gender-affirming hormone treatment, possibly due to conversion of administered testosterone. In transgirls androstenedione levels did not change during either GnRHa or gender-affirming hormone treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Implications<\/jats:title><jats:p>No deleterious effects of treatment on adrenal androgen levels were found during approximately 4 years of follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Strengths &amp; Limitations<\/jats:title><jats:p>This is one of the largest cohort of adolescents with GD, treated using a uniform protocol, with standardized follow-up. The lack of a control group is a limitation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The changes in androstenedione levels during GnRHa and gender-affirming hormone treatment in transboys may not be of adrenal origin. The absence of changes in androstenedione levels in transgirls or DHEAS levels in either sex during gender-affirming hormone treatment suggests that gender-affirming hormone treatment does not significantly affect adrenal androgen production.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.jsxm.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T01:27:03Z","timestamp":1537061223000},"page":"1357-1363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria"],"prefix":"10.1093","volume":"15","author":[{"given":"Sebastian E.E.","family":"Schagen","sequence":"first","affiliation":[{"name":"Department of Pediatrics \u00a0 , Leiden , the Netherlands"},{"name":"Leiden University Medical Center \u00a0 , Leiden , the Netherlands"},{"name":"Department of Pediatric Endocrinology \u00a0 , Amsterdam , the Netherlands"},{"name":"VU University Medical Center \u00a0 , Amsterdam , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Lustenhouwer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u00a0 , Leiden , the Netherlands"},{"name":"Leiden University Medical Center \u00a0 , Leiden , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy T.","family":"Cohen-Kettenis","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology and Medical Social Work \u00a0 , Amsterdam , the Netherlands"},{"name":"VU University Medical Center \u00a0 , Amsterdam , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette A.","family":"Delemarre-van de Waal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u00a0 , Leiden , the Netherlands"},{"name":"Leiden University Medical Center \u00a0 , Leiden , the Netherlands"},{"name":"Department of Pediatric Endocrinology \u00a0 , Amsterdam , the Netherlands"},{"name":"VU University Medical Center \u00a0 , Amsterdam , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine E.","family":"Hannema","sequence":"additional","affiliation":[{"name":"Department of Pediatrics \u00a0 , Leiden , the Netherlands"},{"name":"Leiden University Medical Center \u00a0 , Leiden , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"2023012309355208300_bib1","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023012309355208300_bib2","article-title":"Standards of care for the health of transsexual, transgender and gender non-conforming people","author":"World Professional Association for Transgender Health"},{"key":"2023012309355208300_bib3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1542\/peds.2013-2958","article-title":"Young adult psychological outcome after puberty suppression and gender reassignment","volume":"134","author":"de Vries","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"2023012309355208300_bib4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3742","article-title":"Hormonal treatment in young people with gender dysphoria: a systematic review","volume":"141","author":"Chew","year":"2018","journal-title":"Pediatrics"},{"key":"2023012309355208300_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-8587(17)30099-2","article-title":"Puberty suppression in transgender children and adolescents","volume":"5","author":"Mahfouda","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023012309355208300_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.33549\/physiolres.930385","article-title":"Dehydroepiandrosterone\u2014is the fountain of youth drying out?","volume":"52","author":"Celec","year":"2003","journal-title":"Physiol Res"},{"key":"2023012309355208300_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2265.1995.tb02611.x","article-title":"Effects of gonadal androgens and estrogens on adrenal androgen levels","volume":"43","author":"Polderman","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023012309355208300_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2006-925198","article-title":"Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals","volume":"38","author":"Mueller","year":"2006","journal-title":"Horm Metab Res"},{"key":"2023012309355208300_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1515\/cclm.2002.202","article-title":"Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults","volume":"40","author":"Elmlinger","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"2023012309355208300_bib10","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/cen.12612","article-title":"Reference values for serum dehydroepiandrosterone-sulfate in healthy children and adolescents with emphasis on the age of adrenarche and pubarche","volume":"82","author":"Guran","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023012309355208300_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/jcem-59-3-551","article-title":"Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood","volume":"59","author":"Orentreich","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023012309355208300_bib12","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1373\/clinchem.2010.143222","article-title":"Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals","volume":"56","author":"Kushnir","year":"2010","journal-title":"Clin Chem"},{"key":"2023012309355208300_bib13","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023012309355208300_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/humrep\/del474","article-title":"Association between polycystic ovary syndrome and female-to-male transsexuality","volume":"22","author":"Baba","year":"2007","journal-title":"Hum Reprod"},{"key":"2023012309355208300_bib15","first-page":"1018","article-title":"Transsexualism in Serbia: a twenty-year follow-up study","volume":"6","author":"Vujovic","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2023012309355208300_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/00365519609090583","article-title":"Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia","volume":"56","author":"Eri","year":"1996","journal-title":"Scand J Clin Lab Invest"},{"key":"2023012309355208300_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jcem-72-2-426","article-title":"High testosterone levels of ovarian origin affect adrenal steroidogenesis?","volume":"72","author":"Fruzzetti","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023012309355208300_bib18","first-page":"747","article-title":"Consecutive cyproterone acetate and estradiol treatment in late-pubertal transgender female adolescents","volume":"14","author":"Tack","year":"2017","journal-title":"J\u00a0Sex Med"},{"key":"2023012309355208300_bib19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.fertnstert.2015.02.003","article-title":"Antimullerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy","volume":"103","author":"Caanen","year":"2015","journal-title":"Fertil Steril"},{"key":"2023012309355208300_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/jcem-72-5-1025","article-title":"The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women","volume":"72","author":"Azziz","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023012309355208300_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2265.1994.tb03010.x","article-title":"Testosterone administration increases adrenal response to adrenocorticotrophin","volume":"40","author":"Polderman","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023012309355208300_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1210\/jcem-66-1-128","article-title":"Effect of androgen on adrenal steroidogenesis in normal women","volume":"66","author":"Vermesh","year":"1988","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"2023012309355208300_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1677\/joe.0.1590373","article-title":"Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells","volume":"159","author":"Rossi","year":"1998","journal-title":"J\u00a0Endocrinol"},{"key":"2023012309355208300_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00428-007-0542-0","article-title":"Expression of aromatase and estrogen receptors in human adrenocortical tumors","volume":"452","author":"Barzon","year":"2008","journal-title":"Virchows Arch"},{"key":"2023012309355208300_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jsbmb.2009.01.013","article-title":"Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells","volume":"113","author":"Granata","year":"2009","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"2023012309355208300_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/bj1270649","article-title":"Isolation and characterization of 17-hydroxy steroid dehydrogenase from human erythrocytes","volume":"127","author":"Mulder","year":"1972","journal-title":"Biochem J"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518311020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518311020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/9\/1357\/48590157\/jsm_15_9_1357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/9\/1357\/48590157\/jsm_15_9_1357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T04:13:30Z","timestamp":1693887210000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/15\/9\/1357\/6980469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,1]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.07.017","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}